Abstract: Multilocus haplotype analysis of candidate variants with genome wide association studies (GWAS) data may provide evidence of association with disease, even when the individual loci themselves do not. Unfortunately, when a large number of candidate variants are investigated, identifying risk haplotypes can be very difficult. To meet the challenge, a number of approaches have been put forward in recent years. However, most of them are not directly linked to the disease-penetrances of haplotypes and thus may not be efficient. To fill this gap, we propose a mixture model-based approach for detecting risk haplotypes. Under the mixture model, haplotypes are clustered directly according to their estimated disease penetrances. A theoretical justification of the above model is provided. Furthermore, we introduce a hypothesis test for haplotype inheritance patterns which underpin this model. The performance of the proposed approach is evaluated by simulations and real data analysis. The results show that the proposed approach outperforms an existing multiple testing method.
Introduction
The advanced genotyping technology and the availability of a large number of dense single nucleotide polymorphisms (SNPs) across human genome have enabled the design of genome-wide association studies (GWAS) for complex diseases. These studies have progressed from genotyping the SNPs over thousands of case and control subjects (Hindorff et al., 2009) , producing large, high-dimensional genotype datasets. The rapid increase in the number of GWAS provides an unprecedented opportunity to examine the effects of rare SNPs on disease susceptibility by the integrative analysis of these data under the assumption that both common and rare SNPs contribute to the underlying genetic mechanisms of complex diseases Zhu et al., 2010) . It is generally believed that jointly analyzing rare SNPs within a region of strong linkage disequilibrium can be more informative and effective than individual SNP analysis, as multiple SNPs influence the risk of complex diseases in aggregate (Schaid et al., 2002; Tzeng et al., 2006; Morris, 2006; Li et al., 2011; Stranger et al., 2011) . The multilocus haplotype, the ordered allele sequences on a chromosome, provides a nature unit of analysis for capturing linear and non-linear correlations in SNPs (Zhang et al., 2003) . Unfortunately, the multi-SNP analysis discussed above can suffer from high-dimensional problems that are associated with many predictors, some of which are highly correlated. A popular strategy, suggested by the block-like structure of the human genome, is to divide each chromosome into a list of genetically meaningful regions to reduce the dimensions of these genotype data. Direct, laboratory-based haplotyping to infer the unknown phase are expensive ways to obtain haplotypes. So, in a typical haplotype-based association analysis, people infer haplotypes together with their population frequencies in cases and controls from observed genotypes by using the software such as PHASE (Stephens et al., 2001; Scheet and Stephens, 2006) . The empirical evidence suggests that the majority of the polymorphism is concentrated on a relatively small number of haplotypes while the rest is sparsely spread over a number of categories. These non-common haplotypes can be rare and thus hard to assess their disease-susceptibility (Schaid et al., 2002; Tzeng et al., 2006) .
Haplotype clustering offers a promising avenue for addressing the above issue. Over the past decade, enormous progress has been made in this direction and various methods of clustering have been developed on the basis of haplotype similarity and evolution characteristics (Molitor et al., 2003; Tzeng et al., 2006; Browning and Browning, 2007; and references therein) . However, none of them except Zhu et al. (2010) has explored advantage of the haplotype similarity in terms of their contributions to disease risks. Zhu et al. (2010) implemented a method for clustering rare risk haplotypes by performing multiple mariginal Z-tests for the significant differences between retrospective haplotype frequencies in cases and controls, on the basis that rare risk haplotypes can be enriched in cases. The method of Zhu et al. (2010) may be too naive to be efficient. Therefore, it is desirable to develop a model-guided approach for haplotype clustering. Here, we propose a prospective model for haplotype counts in cases and controls, where given the marginal counts of haplotypes, the disease status of each haplotype follows a binomial mixture distribution. The main advantage of the proposed model over the other existing methods is that it allows the clustering to be directly linked to the haplotype disease-penetrances. Our intuition is as follows. We arrange the haplotype frequencies derived from a case-control study by a contingency table, where rows stand for the disease status (case or control) and columns for haplotypes. Then, we can directly assess whether two haplotypes belong to the same group by their column similarity in the table. To do that, we fit each column by a binomial distribution with the disease-penetrance as the success probability and group these columns by use of a binomial mixture. To account for the variation of disease-penetrances of haplotypes within risk and non-risk groups, the diseasepenetrances are assumed to be random factors following certain prior distributions. Note that using the estimated prospective haplotype frequencies derived from a retrospective study to estimate disease odds ratio is known to be asymptotically consistent even though the disease-penetrance estimators may not be (Prentice and Pyke, 1979) .
We employ the expectation-maximization (EM) algorithm to calculate the maximum likelihood estimator for the proposed mixture model. The EM algorithm can guarantee monotone convergence to a local maximum. In this paper, taking advantage of the fact that the disease-penetrance can be varying across different risk haplotypes, we propose a Bayesian regularization procedure to improve the proposed mixture model and the corresponding EM algorithm by posterior sampling. We show its superior performance over the existing EM algorithm by simulations. We also conduct a large scale simulation studies on the proposed clustering method in both prospective and retrospective design settings, showing that the proposed method can outperform the approach of Zhu et al. (2010) in most cases. We apply both the proposed method and the method of Zhu et al. (2010) to the Coronary Artery Disease (CAD) and Hypertension (HT) data in the Wellcome Trust Case Control Consortium (WTCCC), identifying potential risk haplotypes for each pre-specified chromosomal region.
The rest of the paper is organized as follows. The proposed methodology and some theory are introduced in Section 2. The simulation studies and real data applications are presented in Section 3. Discussions and conclusion are made in Section 4. Some technical details can be found in the online supplementary material.
Methodology
Consider a case-control sample with N 0 controls and N 1 cases, typed at a list of pre-specified SNP markers in a candidate region, yielding unphased (multi-locus) genotype set G. Let H j , 1 ≤ j ≤ J denote the distinct (multi-locus) haplotypes inferred from G with haplotype counts n 0j , 1 ≤ j ≤ J in controls summing to 2N 0 , and n 1j , 1 ≤ j ≤ J in cases summing to 2N 1 respectively. The respective frequencies of the jth haplotype in controls and cases can be estimated by r 0j = n 0j /(2N 0 ) and r 1j = n 1j /(2N 1 ), respectively. Similarly, letting n j = n 0j +n 1j , the prospective frequencies of the jth haplotype in cases and controls can also be estimated by p 0j = n 0j /n j and p 1j = n 1j /n j , respectively. When a haplotype is unevenly distributed between cases and controls, its odds ratio (OR) will be deviated from one and it is likely to be a risk haplotype. Therefore, multiple OR tests can be used for detecting risk haplotypes. Here, we opt for multiple OR testing, because risk haplotypes can directly be assessed by using their disease-penetrances via the OR values (Jewell, 2004) . The main thrust of our proposal below is to perform a model-based clustering on haplotypes before the OR testing. This can help reduce the number of haplotypes to be tested and thus reduce the multiple OR testing error.
Two-stage standard mixture approach
Our standard two-stage approach is processed as follows.
Stage 1 (Model-based clustering): We hypothesize that haplotypes are either risk or non-risk, where nonrisk means neutral or protective to the disease. Under this assumption, given the haplotypes H j , 1 ≤ j ≤ J and their the marginal counts (n 1 , . . . , n J ), the conditional distribution of the counts n = {(n 0j , n 1j )
T :1 ≤ j ≤ J} are modelled by the two-component binomial mixture,
where p r = P(affected|H r ) and p r = P(affected|H r ) are the disease-penetrances of risk haplotype H r and non-risk haplotype H r , respectively, and
The unknown parameter θ = (p r , p r , π) T can be estimated by maximizing the log-likelihood
Note that the direct calculation of the above maximum likelihood estimator (MLE) is difficult. Instead, we calculate it indirectly by the EM algorithm (McLachlan and Basford, 1988 
Then, the so-called complete-data log-likelihood can be written as
Given the current value θ (t) = (p r (t) , p r (t) , π (t) ) T and the data n, we first calculate the current log-likelihood l(θ (t) |n). Then, in the E-step, we calculate the expectation of the complete-data log-likelihood with respect to I,
In the M-step, we update θ (t) by solving the partial derivatives equations
We obtain
jr (n 1j + n 0j )
.
We calculate the updated log-likelihood l(θ (t+1) |n) and its absolute distance to the previous l(θ (t) |n) and
Start with the initial value θ (0) , we alternatively run the E-step and the M-step for t = 0, 1, . . . , till err
is less than a pre-specified value d 0 (we set d 0 = 0.0001 in our codes). Suppose that the algorithm stops at (t+1) th iteration. Note that τ are the posterior probabilities of the j-th haplotype being in risk and non-risk haplotype clusters, respectively. So, based on these quantities, the estimated risk and non-risk haplotype clusters can be defined by
We consider the two methods to choose the initial values for the EM algorithm: random initialization and data initial partition. See Karlis and Xekalaki (2003) 
where adding 0.5 to the counts before computing the odds ratio was suggested by Agresti (1999) for continuity correction. Note that under the null hypothesis that the haplotype is evenly distributed between cases and controls,
where
Then, the risk haplotype set S (t+1) r (which are significant in the OR test) is updated bŷ
where c 1 is a pre-specified critical value for testing (invoking the Bonferroni adjustment, we set c 1 = 2.6 in the later simulations and c 1 = 5.3 in the real data analysis). The non-risk haplotype set is updated bŷ
Given the clustersŜ r andŜr, the estimators of π, p r and p r are updated bŷ
The population frequencies ofŜ r andŜr, P(H ∈Ŝ r ), and P(H ∈Ŝr), are estimated by their retrospective frequencies in controls,P
Note that according to the theory of Prentice and Pyke (1979) , the OR based onp r andpr above is asymptotically insensitive to the case-control sample ratio althoughp r andpr can be affected by the ratio.
Two-stage hybrid mixture approach
In the previous mixture model, risk haplotypes are assumed to have the same disease-penetrance and so are non-risk haplotypes. Such a homogenous assumption may not hold in reality. To allow for the diseasepenetrance variations within each group, we take p r and p r as random factors by imposing prior distributions on them. The resulting model is called a Bayesian regularized mixture model. The details are as follows.
Bayesian regularization: We first randomly generate i 0 (say i 0 = 100) initial values at which we calculate the log-likelihoods, and take the one, which attains the maximum and is denoted by 
T , we have the expected values of I jr and I jr say τ
jr and τ
jr . Haplotype clusters can be defined by
jr }.
Collapse haplotypes in S r and calculate the counts of the collapsed S r in controls and cases, s 0r and s 1r . Similarly, collapse S r and calculate the counts of the collapsed S r in controls and cases, s 0r and s 1r . Based on these counts, the likelihood functions of p r and p r can be written as
Let p δ1 r (1−p r ) δ0 and p δ0 r (1−pr) δ1 denote the conjugate priors for p r and p r , respectively, with the pre-specified pseudo-counts δ 0 and δ 1 . We expect that a risk haplotype appears more frequently in cases than does any non risk haplotype. So, the pseudo-counts should satisfy the constrain δ 1 > δ 0 . They should also be small compared to the number of cases. In this paper, we set δ 1 = 8 and δ 0 = 2. In our simulations, we found the results are not very sensitive to the choice of these constants. After setting the above priors, we then derive the posteriors,
We draw q 
Finally, we repeat the above procedure until the absolute difference between the estimates of θ in two consecutive iterations is less than a pre-specified value, say 0.0001.
In the Online Supplementary Material (Appendix II), we show the superiority of the Bayesian regularized M-step over the standard M-step by simulations. In light of this, we replace the M-step in the EM by the Bayesian regularized M-step to form a hybrid EM algorithm. In summary, we opt for the following two-stage hybrid mixture approach for association analysis in the remaining paper:
Stage 1 (Clustering): Use the hybrid EM algorithm to estimate the two-component binomial mixture model.
Stage 2 (OR testing):
Use the OR statistic to test for risk haplotypes further as before.
Model justification
To make the proposed model identifiable, we need to assume that the disease-penetrance ratio p r /p r > 1, that is, risk haplotypes are more enriched in cases than non-risk haplotypes. In this section, under the commonly used inheritance models, we prove the above hypothesis holds when the so-called relative risk measure is larger than one. For this purpose, let S r and S r denote the risk and non-risk haplotype sets in the population. Suppose that the disease-penetrance of a genotype depends only on the number of risk haplotypes contained in that genotype. Then, we have three types of penetrance:
where H r ∈ S r and H r ∈ S r . Denote the relative risk measures λ 1 = f 1 /f 0 and λ = f 2 /f 0 . In the Online Supplementary Material (Appendix III), we show that the haplotype disease-penetrances, P(affected|H r ) and P(affected|H r ) are linear functions of the relative risk measures of genotypes and the population haplotype frequencies, namely
where P(H r ), P(H ∈ S r ) and P(H ∈ S r ) are the population frequencies of H r , S r and S r . The disease-penetrance ratio between risk and non-risk haplotypes,
We can further show that under the commonly used models of inheritance (multiplicative, dominant, and recessive), the haplotype relatively risk (i.e. the the disease-penetrance ratio between the risk and non-risk haplotypes) is larger than one if and only if the corresponding genotype relative risk is larger than one. The above results imply that when the genotype relative risk λ > 1, the individuals carrying the risk haplotype H r will have more chance of getting the disease than do non-risk haplotype carriers; when λ < 1, the individuals carrying H r have the less chance of getting the disease than do non-risk haplotype carriers and thus H r plays a disease-protective role.
Testing for haplotype inheritance modes
In the previous subsection, we develop a theory on the identification of the proposed model under certain inheritance assumption on hyplotypes. However, the biological justification for the choice of an inheritance model is seldom available and lack of a statistical justification for the specific genetic model is customary practice. To address the issue, we introduce a statistical test as follows.
We begin with deriving non-parametric estimators of the genotype disease-penetrances. Suppose that we have obtainedŜ r andŜr, the estimated risk and non-risk haplotype sets from our hybrid mixture approach. Let G 0 be the set containing the observed genotypes which consist of two haplotypes inŜr, G 1 the set containing the observed genotypes which consist of one haplotype inŜ r and one inŜr, and G 2 containing the observed genotypes which consist of two haplotypes inŜ r . For K = 0, 1, 2, we then calculate the total haplotype frequencies of G k in controls and cases, denoted by (n 02 , n 12 ), (n 01 , n 11 ), (n 00 , n 10 ), respectively. Then the disease-penetrances of genotypes can be estimated non-parametrically bŷ f 0 = n 10 n 10 + n 00 ,f 1 = n 11 n 01 + n 11 ,f 2 = n 12 n 02 + n 12
Let A denote the set of the above three inheritance modes: the multiplicative, the dominant, and the recessive. We assume that genotypes linked their underlying haplotype pairs via the Hardy-Weinberg equilibrium. To test for an inheritance mode, for a ∈ A and k = 0, 1, 2, we first derive a parametric estimator of f k , sayf (a) k by using the estimatorsp r ,pr,P(Ŝr) obtained in the previous subsection. We then calculate the statistic
We calculate the minimum D A = min a∈A D a and recordâ at which D a attains the minimum. We expect that D A takes small values when one of modes in A is true. We can quantitatively justify the significance by use of the following parametric bootstrap test: We re-sampling genotypes M times on the basis of the estimated modeâ with the estimated penetrancesf To conclude this section, we now state the formulas for estimating the relative risk measures under the three inheritance models. The proofs are straightforward and thus omitted. We use the notations λ = f 2 /f 0 and λ 1 = f 1 /f 0 introduced before. -Multiplicative model, where λ = λ 2 1 . We havê
-Dominant model, where λ = λ 1 . We havê
-Recessive model, where λ 1 = 1. We havê λ = (p r /pr −P(Ŝr))/P(Ŝ r ),f 1 =f 0 =pr ,f 2 =λf 0 .
Simulation studies
In this section, via simulations we will examine the performance of the proposed methods in terms of the estimated L 1 bias and the average of sensitivity and specificity under various scenarios. Letθ be the estimator of θ, andŜ r andŜr the estimators of the true risk and non-risk haplotype sets S r and S r , respectively. Then, by the L 1 bias we mean the L 1 distance betweenθ and θ. The sensitivity and specificity ofŜ r andŜr are defined as sen = |Ŝr∩Sr| |Sr| and spe = |Ŝr∩Sr| |Sr| . We take the average AVSS = (sen+spe)/2 to assess the performance of the haplotype classification above. As pointed out before, in light of our simulation study reported in the Online Supplementary Material (Appendix II), we adopted the two-stage hybrid mixture approach in the simulations and real data analysis below.
Performance of the proposed hybrid mixture approach
Note that the proposed hybrid mixture method is based on the prospective likelihood model although real data can be from retrospective studies. By the simulations below, we addressed whether the proposed hybrid mixture approach could outperform the multiple-testing procedure of Zhu et al. (2010) in both prospective (i.e. cohort) and retrospective (i.e. case-control) studies. See the Online Supplementary Material (Appendix IV) for the details of the procedure of Zhu et al. (2010) .
Setting 1 (cohort design):
We generated 30 datasets, each with N 1 case-genotypes and N 0 control-genotypes. They were obtained by the following steps. In the first two steps, we adopted the same approach for generating N 0 + N 1 genotypes which contained m r risk haplotypes as we did in the Online Supplementary Material (Appendix II). In the third step, we simulated the disease status of each genotype by sampling from a Bernoulli distribution. The Bernoulli distribution took f 0 , or λ 1 f 0 , or λf 0 as a success probability according to whether the genotype contained zero, one or two risk haplotypes. We considered the three inheritance models coded by IM: the multiplicative (IM = 1), the dominant (IM = 2) and the recessive (IM = 3). Note that the values of (N 0 , N 1 ) may vary across different datasets. We considered the scenarios with various combinations of (N 0 + N 1 , m r , IM, f 0 , λ, m r ), where N 0 +N 1 = 3000, 5000, m r = 5, 10, 20, IM = 1, 2, 3, f 0 = 0.1, λ = 1, 1.4, 1.8, 2.2, 2.6, 3, 3.4, and 3.8, respectively. For each scenario, we applied both the hybrid mixture method and the multiple testing method to 30 datasets and calculated their AVSS values, respectively. For each of the three inheritance models, we plotted the means of these AVSS values over 30 datasets against λ. The results in Figure 1 show that on the cohort data, the hybrid mixture method performed substantially better than the multiple testing method in all the scenarios defined above.
Setting 2 (case-control design):
We generated 30 datasets, each of which were simulated by the following two steps.
Step 1, to generate N 1 case-genotypes, we first drew 2N 1 haplotypes by the software MS with mutation rate of 2, of which m r haplotypes were labeled as risk haplotypes see Hudson (2002) . We then randomly paired these haplotypes to form N 1 case-genotypes. Let G j , 1 ≤ j ≤ J, be all the different genotypes contained in the N 1 cases and r 1j , 1 ≤ j ≤ J, be the retrospective frequencies. These case-genotypes formed three groups according to the number of risk haplotypes which each genotype contained: each genotype in Groups 0, 1 and 2 contained two non-risk haplotypes, only one risk-haplotype, and two risk haplotypes, respectively.
Step 2, we generated N 0 control-genotypes, which also had genotypes G j , 1 ≤ j ≤ J, but with population retrospective frequencies q 0j , 1 ≤ j ≤ J. We first let q 0j , 1 ≤ j ≤ J depend on the pre-specified constant d by
G j belong to Group 2 r 1j (1 − 0.5d/r 1g1 ) G j belong to Group 1 r 1j (1 − 1.5d/r 1g0 ) G j belong to Group 0 where r 1g k = ∑︀ G j ∈ Group k r 1j for K = 0, 1, 2, and d ≥ 0 is a parameter to reflect the effects of risk haplotypes on genotype frequencies. We simulated N 0 control-genotype counts from the multinomial model MN(N 0 , (q 01 , . . . , q 0j ) T ) and calculated the corresponding retrospective frequencies r 0j , 1 ≤ j ≤ J. We considered the cases where m r = 5, 10, 20, and d = 0, 0.05, 0.1, 0.15, 0.2, 0.25, 0.3, and 0.35, respectively. For each dataset, the cumulative genotype frequencies of Groups 0, 1, and 2 in controls are r g0 + 1.5d, r g1 + 0.5d, and r g2 − d, respectively, whereas the corresponding frequencies in cases are r g0 , r g1 and r g2 , respectively. This implies that due to the impacts of risk haplotypes, the cumulative frequencies of Groups 2 and 1 in cases have been increased compared to those in controls. The odds ratios between Groups 2 and In these plots, the red and the blue solid curves, showing means of the AVSS values (i.e. the values of (specificity and sensitivity)/2) over 30 datasets, were plotted against the values of λ for the hybrid mixture method and the multiple testing method, respectively. The two red dash curves are one standard deviation up and down from the red mean curves. Similarly, the two blue dash curves are one standard deviation up and down for blue mean curves.The plots in the columns from the left to the right are for the cases where there were 5, 10, and 20 risk haplotypes in the underlying haplotypes. The top two rows, the middle two rows and the bottom two rows are the results for (N 0 , N1) = (2000, 1000), (3000, 2000) under the multiplicative, the dominant and the recessive inheritance models, respectively. We applied the hybrid mixture method and the multiple testing method to these case-control data. The mean curves of the AVSS values with one standard error up and down were plotted against the d values in Figure 2 . The results again demonstrate that the hybrid mixture method can be more powerful than the multiple testing method in detecting risk haplotypes.
Performance of the proposed inheritance mode test
For each of the three inheritance models, we generated 30 datasets. Each dataset was simulated as follows. Following the cohort design, we first simulated N 0 +N 1 genotypes, where the underlying haplotypes contained m r = 10 risk-haplotypes and followed the Hardy-Weinberg equilibrium. We then simulated their disease status by use of the inheritance models with m r = 0.1 and λ = 1, 1.4, 1.8, 2.2, 2.6, 3, 3.4, and 3.8, respectively as we did in the previous subsection.
For each dataset, we calculated D A and the optimal modeâ. We generated M parametric bootstrap samples of the genotype frequencies based on the modeâ and calculated the corresponding values of the inheritance testing statistic, D
(k)
A , K = 1, . . . , M. Based on these values, we obtained the empirical p-value. We calculated the success rates by counting how many times thatâ is the true mode over the 30 datasets for each λ. These success rates and the empirical p-values are displayed in Figure 3 . The results indicate that the success rates and p-values are increasing in λ. The box-whisker plots in Figure 3 also show that almost all the empirical p-values are above 0.20, suggesting that almost all the tests are not significant. Therefore, the bootstrap test has a very high power in finding the true inheritance modes in the data.
Real data analysis
We applied the proposed hybrid mixture approach to the GWAS genotype datasets on coronary artery disease (CAD) and hypertension (HT) obtained by Affymetrix 500K SNP chips in the WTCCC study (WTCCC, 2007) . Each dataset contained 2000 unrelated cases as well as 3000 unrelated controls. The controls came from two sources: 1500 from the 1958 British Birth Cohort (58C) and 1500 from the three National UK Blood Services (NBS). There were about 500600 SNPs across the human genome. These data were downloaded from the WTCCC website. We first pre-processed the data by excluding the SNPs which meet one of the following criteria: (1) the HWE Fisher test p-value is less than 10 −8 in controls; (2) the χ 2 test p-value between 58C and NBS is less than 10 −8 ; (3) the minor allele frequency is less than 1%; (4) the calling score is less than 95%.
After the exclusion, around 4897746 SNPs remained for the analysis. We divided the genome into regions (or blocks) of around eight SNPs according to their positions on the chromosomes, obtaining 61218 regions. Note that the long block will dilute the effects of risk SNPs whereas the short block will miss interactions between SNPs. The block length of eight was chosen to achieve a compromise between the above aspects. Also note that as we excluded the SNPs with bad callings, the numbers of cases and controls are varying across the different regions. For all regions, we first reconstructed the haplotype pairs of genotypes by use of the software PHASE, to which we applied Stage 1 of the hybrid procedure. It led to 902909 haplotypes and 961942 haplotypes to be declared as risk haplotypes at Stage 1 for the CAD and the HT, respectively. We then calculated the OR tests on these haplotypes at Stage 2. In Stage 2, according to the Bonferroni adjustment, the individual significance level was set at the levels of 0.05/902909 = 5.5 × 10 −8 and 0.05/961942 = 5.2 × 10 −8 for the CAD and the HT, respectively. These individual significance levels were then used to determine the thresholding level c 1 in the multiple OR thresholding, which is c 1 = 5.3. After performing the proposed hybrid mixture procedure on the datasets, we obtained the estimated risk and non-risk haplotype sets,Ŝ r andŜr, for the CAD and the HT, respectively.
Note that there were two sub-populations in controls. Any estimated risk haplotype which is significant in differing two control sub-populations should be viewed as an artifact. By using this, we made further quality control on the selected haplotypes by running the χ 2 tests on the association of two control sub-populations with each selected risk haplotype. We eliminated these risk haplotypes whose p-values for the above χ 2 tests were < 30%. Here, 30% was chosen by the simulations in the Supplementary Web Material, aiming to filter out these artificial risk haplotypes with parameter d = 0.05. From the simulations, we can see that when d = 0.05, these p-values would be less than or equal to 0.30 most times. Finally, we calculated the ORs for all the estimated haplotypes and thresholded them by using the bound exp(c 1 √︀ 1/(n 0H + 0.5) + 1/(n 1H + 0.5) + 1/(n 0r + 0.5) + 1/(n 1r + 0.5)) with c 1 = 5.3. This gave the final risk-haplotype set as displayed in Tables 1 and 2 below. In the tables, each haplotype has been assigned to a physically closest gene on the basis of the information provided the GWAS catalog and the genetic information from the British 1958 Birth cohort. See Welter et al. (2014) and the web page at http://www2.le.ac.uk/projects /birthcohort/1958bc. In the CAD case, we did rediscover the CAD In the Table, the p-values were derived from the χ 2 test of the frequencies of Hi against the collapsed frequencies of the estimated non-risk haplotypes.
risk gene CDKN2B and the risk haplotype "GGTGCCAG" found by the previous study (WTCCC, 2007; Zhu et al., 2010) . We also tested the inheritance modes for these risk haplotypes. Taking the gene CDKN2B as an example, we obtained D A = 0.4087 with dominant mode and the empirical p-value of 0.97, suggesting that the hyplotype "GGTGCCAG" in the gene followed the dominant inheritance mode. In the Table, the p-values were derived from the χ 2 test of the frequencies of Hi against the collapsed frequencies of the estimated non-risk haplotypes.
Discussion and conclusion
The GWAS and sequencing studies have produced a huge amount of high-dimensional data. Analyzing these data offers many challenges to statistical inference. Several empirical studies have demonstrated the superiority of SNP region-based association analysis over single-SNP strategy (see Zakharov et al., 2013 and reference therein) . However, even restricted to a region, we may still obtain many sparsely distributed haplotypes derived from phasing the genotypes. In this case, the traditional generalized linear model-based approach (Schaid et al., 2002) may not be effective in detecting rare disease-associated haplotypes. In the presence of sparsely distributed haplotypes, haplotype clustering is very useful for performing statistical analysis on such kinds of data. Most of the existing methods of haplotype clustering are heuristic and not diseasepenetrance based. To overcome this drawback, we have proposed a hybrid mixture model-based approach for grouping and identifying risk haplotypes. The key ingredient of the approach is a prospective mixture model with priors. The proposal includes two stages: in the stage 1, one groups haplotypes and therefore reduce the haplotype sparsity, while in the second stage, one conducts a two-sample Z-test based screening on the haplotypes derived from the previous stage. We have also provided a test for genetic inheritance modes. We have hypothesized that haplotypes are either risk or non-risk, where non-risk means neutral or protective to the disease. However, if we are also interested in identifying protective haplotypes, we can easily extend the current framework to address the issue by use of a three-component binomial mixture model. We have examined the performance of the proposed procedure by a theoretical analysis, simulations and a real data analysis. We have showed that under the Hardy-Weinberg equilibrium, the risk haplotype group is identifiable if genotype relative risk is not equal to one. Compared to the standard multiple Z-testing method, the proposed procedure is more efficient in terms of sensitivity and specificity. We applied our procedures to the WTCCC CAD and hypertension data, rediscovering some existing risk gene and haplotypes and identifying many more risk haplotypes than did the multiple Z-test based approach. This is not surprising as the simulations have already demonstrated that the model-based clustering often performs better than does the multiple Z-test approach.
We note that the proposed mixture model can be combined with haplotype-based logistic regression to account for covariates. However, further studies are beyond the scope of the paper.
Description of online supplementary materials:
Online supplementary material contains further information about the initialization of the EM algorithm, the performance of the proposed Bayesian regularization, the proof of the disease-penetrance formulas, and the multiple Z-testing method.
